MedPath

Effect of supplementation in treatment of Coronary Heart Disease

Phase 3
Conditions
Coronary Heart Disease.
Ischaemic heart disease (chronic) NOS
I25.9
Registration Number
IRCT201510315623N56
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Subjects aged 40-85 years
Diagnosed with type 2 diabetes and coronary heart disease

Exclusion Criteria

Consuming vitamin D supplements within the past 3 months
Having an acute myocardial infarction within the past 3 months
Having cardiac surgery within the past 3 months
Important hepatic failure
Adequate vitamin D status

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin. Timepoint: At the beginning of the study and after 24 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 24 weeks of intervention. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath